Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Huarong Rongde Asset Management

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 5
Average round size
info
The average size of a deal this fund participated in
$126M
Portfolio companies 5
Rounds per year 0.28
Lead investments 0
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Biopharma
  • Life Science
Summary

Huarong Rongde Asset Management appeared to be the VC, which was created in 2006. The venture was found in Asia in China. The leading representative office of defined VC is situated in the Beijing.

The typical case for the fund is to invest in rounds with 4 participants. Despite the Huarong Rongde Asset Management, startups are often financed by Kunlun. The meaningful sponsors for the fund in investment in the same round are Sino-Ocean Capital, Deutsche Bank, Clearwater Capital Partners LLC.

Among the various public portfolio startups of the fund, we may underline Nash Work For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are Coworking, Office Administration.

The important activity for fund was in 2018. Deals in the range of 50 - 100 millions dollars are the general things for fund. The fund is constantly included in less than 2 investment rounds annually.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
AdOutlet.com New York, New York, United States
Alterfin Belgium, Brussels Hoofdstedelijk Gewest, Brussels-Capital
Altimeter California, San Francisco, United States
Barings Equity Partners China, Hong Kong, Hong Kong Island
Bittrex Support Liechtenstein, Vaduz, Vaduz
Black Kite Capital -
C2 Capital Management Chicago, Illinois, United States
Expo Live Dubai, United Arab Emirates
Falcon Network -
Havoc Capital -
HKB Capital -
Kips Chiyoda, Japan
Park Ten Capital -
Peesh Venture Capital Bangalore, India, Karnataka
Shanghai Xiecheng Heli Touzi Qiye China, Qingpu, Shanghai
Sunflower Investment China, Futian, Guangdong
Tobon VC China, Hangzhou, Zhejiang
Upper90 New York, New York, United States
Wideblue Glasgow, Glasgow City, United Kingdom

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Gensciences

Biotechnology
Clinical Trials
Health Care
Pharmaceutical
Product Research
$123M04 Mar 2021 Nantong, Jiangsu, China

Hinova Pharma

Health Care
Pharmaceutical
$154M06 Oct 2020 Qingyang District, Sichuan, China

Biopharma
Biotechnology
Life Science
$278M29 Apr 2020 China, Shanghai

Nash Work

Coworking
Office Administration
$77M07 Jun 2018 China, Beijing

Oriental Arc

Construction
Property Development
Real Estate
$463K07 May 2014 Gusu District, Jiangsu, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Huarong Rongde Asset Management?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 5
Average round size 126M
Rounds per year 0.28
Peak activity year 2020
Lead investments 0
Group Appearance index 0.80

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Gensciences

Biotechnology
Clinical Trials
Health Care
Pharmaceutical
Product Research
$123M04 Mar 2021 Nantong, Jiangsu, China

Hinova Pharma

Health Care
Pharmaceutical
$154M06 Oct 2020 Qingyang District, Sichuan, China

Biopharma
Biotechnology
Life Science
$278M29 Apr 2020 China, Shanghai

Nash Work

Coworking
Office Administration
$77M07 Jun 2018 China, Beijing

Oriental Arc

Construction
Property Development
Real Estate
$463K07 May 2014 Gusu District, Jiangsu, China
Crunchbase icon

Content report

The following text will be sent to our editors: